NCT07090499 2026-03-19A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT05887492 2025-11-18Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsTango Therapeutics, Inc.Phase 1/2 Recruiting126 enrolled
NCT05703516 2025-01-14A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South KoreaNovartisRecruiting250 enrolled
NCT04566432 2024-07-18Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC PatientsGeneplus-Beijing Co. Ltd.Recruiting250 enrolled